MedPath

Clinical evaluation of Mashiningan and Daiokanzoto for the relief of constipation in Parkinson's disease

Not Applicable
Conditions
Constipation of Parkinson&#39
s disease patients
Registration Number
JPRN-UMIN000013879
Lead Sponsor
Division of Oriental Medicine Center for Community Medicine Jichi Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Pregnant women or nursing mothers 2) Patients with apparent obstructions (such as tumors or hernias) in the intestinal tract 3) Patients with drug-induced constipation 4) Patients with known megacolon/megarectum or intestinal pseudo-obstruction 5) Patients who have undergone prior gastrointestinal surgery or abdominal surgery during the 3 months prior to the start of the study 6) Patients with significant cardiac, hepatic, pulmonary, renal, or mental diseases 7) Patients with severe clinical findings or abnormal laboratory (hematology/urinalysis) findings 8) Patients with uncontrolled hypertension, hyperaldosteronism, hypokalemia, or myopathy 9) Patients who may not comply with this research study protocol 10) Patients diagnosed with cancer within 5 years from the start of the study (except for carcinoma in situ) 11) Patients with constipation that is controlled through treatment with Mashiningan or Daiokanzoto prior to the start of this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Constipation assessment scale
Secondary Outcome Measures
NameTimeMethod
1) Bristol stool scale 2) Presence or absence of adverse effects 3) Other individual outcomes, obtained from responses to the questionnaire(Abdominal bloating, stool frequency, sensation of incomplete evacuation, straining, etc.)
© Copyright 2025. All Rights Reserved by MedPath